glycyl-arginyl-glycyl-aspartyl-seryl-proline has been researched along with ryanodine in 1 studies
Studies (glycyl-arginyl-glycyl-aspartyl-seryl-proline) | Trials (glycyl-arginyl-glycyl-aspartyl-seryl-proline) | Recent Studies (post-2010) (glycyl-arginyl-glycyl-aspartyl-seryl-proline) | Studies (ryanodine) | Trials (ryanodine) | Recent Studies (post-2010) (ryanodine) |
---|---|---|---|---|---|
162 | 1 | 20 | 2,894 | 3 | 237 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chan, WL; Holstein-Rathlou, NH; Yip, KP | 1 |
1 other study(ies) available for glycyl-arginyl-glycyl-aspartyl-seryl-proline and ryanodine
Article | Year |
---|---|
Integrin mobilizes intracellular Ca(2+) in renal vascular smooth muscle cells.
Topics: Animals; Antibodies; Calcium; Calcium Channel Blockers; Calcium Channels; Cells, Cultured; Extracellular Space; Fluorescent Antibody Technique; Inositol 1,4,5-Trisphosphate Receptors; Integrins; Intracellular Membranes; Muscle, Smooth, Vascular; Nifedipine; Oligopeptides; Osmolar Concentration; Protein Isoforms; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; Renal Circulation; Ryanodine | 2001 |